NCT06906471Active, not recruitingPhase 1/2
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- First submitted
- 18 Mar 2025
- Start date
- 1 Jul 2026
- Primary completion date
- 30 Oct 2026
- Lead sponsor
- Antelope Surgical Solutions, Inc
- Diseases
- Prostate cancer
- NCT number
- NCT06906471
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 15
- From 1 Jul 2026 to the primary completion date, 30 Oct 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment
Other illness
- Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature
Lab values
- Patients with a creatinine clearance cutoff (CrCl) of \< 60 mL/min
Who the study is looking for
- suspected prostate cancer warranting standard of care multi-core prostate biopsy
Age in the registry: 18 years to 90 years · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HCA Florida Kendall Hospital Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| Icahn School of Medicine at Mount Sinai (ISMMS) Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.